Global Immunotoxins Supply, Demand and Key Producers, 2026-2032
The global Immunotoxins market size is expected to reach $ 2273 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
Immunotoxins are a class of biotherapeutic agents composed of a targeting molecule and a potent cytotoxic protein, constructed through chemical conjugation or genetic engineering fusion. Structurally, they consist of two main components: a targeting moiety, typically an antibody or antibody fragment, which specifically binds to antigens expressed on the surface of target cells; and a toxin moiety derived from bacterial or plant toxins, such as functional domains of diphtheria toxin or ricin. These products are generally formulated as colorless or slightly yellow transparent liquids or as lyophilized powders, and belong to macromolecular protein therapeutics.
Immunotoxins function by binding selectively to target cells via the antibody component, followed by internalization through endocytosis. Once inside the cell, the toxin component is released and disrupts ribosomal function or protein synthesis pathways, ultimately leading to cell death. This mechanism provides high specificity and potent cytotoxicity while minimizing damage to normal cells.
Based on structural design, immunotoxins can be classified into chemically conjugated immunotoxins and recombinant fusion immunotoxins. According to toxin origin, they can be categorized into bacterial-derived and plant-derived types. Their production involves advanced technologies including antibody engineering, toxin modification, recombinant expression, and high-purity purification processes, requiring stringent process control and quality systems. These products are primarily developed by biopharmaceutical and biotechnology companies and are used in the treatment of hematologic malignancies, certain solid tumors, and specific immune-related diseases.
The development opportunities of the immunotoxins market are primarily driven by the advancement of precision medicine and continuous progress in targeted therapy technologies. As molecular classification of tumors becomes more refined, clinical demand for highly selective therapeutic agents has increased significantly. Immunotoxins, with their dual mechanism of targeting and cytotoxicity, demonstrate unique value in specific indications. In particular, for relapsed or refractory hematologic malignancies where conventional therapies are often ineffective, immunotoxins can directly enter target cells and inhibit essential cellular functions, resulting in improved therapeutic response rates. Meanwhile, advances in protein engineering have optimized toxin structures, reduced immunogenicity, extended half-life, and improved safety profiles. In addition, sustained investment in the global biopharmaceutical sector and a more supportive regulatory environment for innovative therapies continue to provide momentum for market growth.
However, the immunotoxins market faces several challenges and risks. The toxin components, being derived from foreign proteins, can trigger immune responses that limit repeat dosing and affect long-term efficacy. Furthermore, the narrow therapeutic window requires precise dosing and patient selection, increasing the complexity of clinical development. On the manufacturing side, production involves handling highly potent toxins and complex protein purification processes, requiring advanced facilities, strict biosafety standards, and robust quality control systems, which contribute to high production costs. Compared with competing technologies such as antibody-drug conjugates, immunotoxins still lag in market awareness and commercialization maturity, limiting their large-scale adoption in the short term.
From the downstream demand perspective, immunotoxins are expanding beyond hematologic malignancies toward broader indications. With continuous discovery of new targets in solid tumors, their potential applications in this field are gradually increasing. Combination therapies are becoming a major trend, including integration with immune checkpoint inhibitors, cell therapies, and other targeted treatments, which may significantly enhance overall efficacy. Under the trend of personalized medicine, there is growing demand for customized therapies targeting specific antigen expression profiles. Additionally, improvements in healthcare systems and payment capabilities in emerging markets are expected to drive demand for advanced targeted therapeutics, creating new growth opportunities.
This report studies the global Immunotoxins demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunotoxins, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunotoxins that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunotoxins total market, 2021-2032, (USD Million)
Global Immunotoxins total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunotoxins total market, key domestic companies, and share, (USD Million)
Global Immunotoxins revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunotoxins total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunotoxins total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunotoxins market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, Pfizer, Novartis, Bristol Myers Squibb, AstraZeneca, Sanofi, AbbVie, Gilead Sciences, Regeneron Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunotoxins market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunotoxins Market, By Region:
1. How big is the global Immunotoxins market?
2. What is the demand of the global Immunotoxins market?
3. What is the year over year growth of the global Immunotoxins market?
4. What is the total value of the global Immunotoxins market?
5. Who are the Major Players in the global Immunotoxins market?
6. What are the growth factors driving the market demand?
Immunotoxins are a class of biotherapeutic agents composed of a targeting molecule and a potent cytotoxic protein, constructed through chemical conjugation or genetic engineering fusion. Structurally, they consist of two main components: a targeting moiety, typically an antibody or antibody fragment, which specifically binds to antigens expressed on the surface of target cells; and a toxin moiety derived from bacterial or plant toxins, such as functional domains of diphtheria toxin or ricin. These products are generally formulated as colorless or slightly yellow transparent liquids or as lyophilized powders, and belong to macromolecular protein therapeutics.
Immunotoxins function by binding selectively to target cells via the antibody component, followed by internalization through endocytosis. Once inside the cell, the toxin component is released and disrupts ribosomal function or protein synthesis pathways, ultimately leading to cell death. This mechanism provides high specificity and potent cytotoxicity while minimizing damage to normal cells.
Based on structural design, immunotoxins can be classified into chemically conjugated immunotoxins and recombinant fusion immunotoxins. According to toxin origin, they can be categorized into bacterial-derived and plant-derived types. Their production involves advanced technologies including antibody engineering, toxin modification, recombinant expression, and high-purity purification processes, requiring stringent process control and quality systems. These products are primarily developed by biopharmaceutical and biotechnology companies and are used in the treatment of hematologic malignancies, certain solid tumors, and specific immune-related diseases.
The development opportunities of the immunotoxins market are primarily driven by the advancement of precision medicine and continuous progress in targeted therapy technologies. As molecular classification of tumors becomes more refined, clinical demand for highly selective therapeutic agents has increased significantly. Immunotoxins, with their dual mechanism of targeting and cytotoxicity, demonstrate unique value in specific indications. In particular, for relapsed or refractory hematologic malignancies where conventional therapies are often ineffective, immunotoxins can directly enter target cells and inhibit essential cellular functions, resulting in improved therapeutic response rates. Meanwhile, advances in protein engineering have optimized toxin structures, reduced immunogenicity, extended half-life, and improved safety profiles. In addition, sustained investment in the global biopharmaceutical sector and a more supportive regulatory environment for innovative therapies continue to provide momentum for market growth.
However, the immunotoxins market faces several challenges and risks. The toxin components, being derived from foreign proteins, can trigger immune responses that limit repeat dosing and affect long-term efficacy. Furthermore, the narrow therapeutic window requires precise dosing and patient selection, increasing the complexity of clinical development. On the manufacturing side, production involves handling highly potent toxins and complex protein purification processes, requiring advanced facilities, strict biosafety standards, and robust quality control systems, which contribute to high production costs. Compared with competing technologies such as antibody-drug conjugates, immunotoxins still lag in market awareness and commercialization maturity, limiting their large-scale adoption in the short term.
From the downstream demand perspective, immunotoxins are expanding beyond hematologic malignancies toward broader indications. With continuous discovery of new targets in solid tumors, their potential applications in this field are gradually increasing. Combination therapies are becoming a major trend, including integration with immune checkpoint inhibitors, cell therapies, and other targeted treatments, which may significantly enhance overall efficacy. Under the trend of personalized medicine, there is growing demand for customized therapies targeting specific antigen expression profiles. Additionally, improvements in healthcare systems and payment capabilities in emerging markets are expected to drive demand for advanced targeted therapeutics, creating new growth opportunities.
This report studies the global Immunotoxins demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunotoxins, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunotoxins that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunotoxins total market, 2021-2032, (USD Million)
Global Immunotoxins total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunotoxins total market, key domestic companies, and share, (USD Million)
Global Immunotoxins revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunotoxins total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunotoxins total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunotoxins market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, Pfizer, Novartis, Bristol Myers Squibb, AstraZeneca, Sanofi, AbbVie, Gilead Sciences, Regeneron Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunotoxins market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunotoxins Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Anthrax Based Toxins
- Diphtheria Toxin (DT) & DT Derivatives
- Pseudomonas Exotoxin (PE) & PE Derivatives
- Ribosome Inactivating Proteins Based Immunotoxins
- Ribonucleases based Immunotoxins
- Others
- Chemical Conjugation
- Recombinant Fusion
- Others
- Bacterial-derived
- Plant-derived
- Synthetic-derived
- Others
- PEGylated
- Glycoengineered
- Mutated Toxin
- Others
- Solid Tumors
- Leukemias
- Roche
- Amgen
- Pfizer
- Novartis
- Bristol Myers Squibb
- AstraZeneca
- Sanofi
- AbbVie
- Gilead Sciences
- Regeneron Pharmaceuticals
- Genentech
- Genmab
- ImmunoGen
- Seagen
- MacroGenics
- Celldex Therapeutics
- Ipsen
- Takeda
- Eisai
- Chugai Pharmaceutical
- Samsung Biologics
- Lonza
- WuXi Biologics
- BeiGene
- Innovent Biologics
- Hengrui Medicine
- Fosun Pharma
- Junshi Biosciences
- CSPC Pharmaceutical
- Ascentage Pharma
1. How big is the global Immunotoxins market?
2. What is the demand of the global Immunotoxins market?
3. What is the year over year growth of the global Immunotoxins market?
4. What is the total value of the global Immunotoxins market?
5. Who are the Major Players in the global Immunotoxins market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Immunotoxins Introduction
1.2 World Immunotoxins Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunotoxins Total Market by Region (by Headquarter Location)
1.3.1 World Immunotoxins Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunotoxins Revenue (2021-2032)
1.3.3 China Based Company Immunotoxins Revenue (2021-2032)
1.3.4 Europe Based Company Immunotoxins Revenue (2021-2032)
1.3.5 Japan Based Company Immunotoxins Revenue (2021-2032)
1.3.6 South Korea Based Company Immunotoxins Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunotoxins Revenue (2021-2032)
1.3.8 India Based Company Immunotoxins Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunotoxins Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunotoxins Consumption Value (2021-2032)
2.2 World Immunotoxins Consumption Value by Region
2.2.1 World Immunotoxins Consumption Value by Region (2021-2026)
2.2.2 World Immunotoxins Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunotoxins Consumption Value (2021-2032)
2.4 China Immunotoxins Consumption Value (2021-2032)
2.5 Europe Immunotoxins Consumption Value (2021-2032)
2.6 Japan Immunotoxins Consumption Value (2021-2032)
2.7 South Korea Immunotoxins Consumption Value (2021-2032)
2.8 ASEAN Immunotoxins Consumption Value (2021-2032)
2.9 India Immunotoxins Consumption Value (2021-2032)
3 WORLD IMMUNOTOXINS COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunotoxins Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunotoxins Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunotoxins in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunotoxins in 2025
3.3 Immunotoxins Company Evaluation Quadrant
3.4 Immunotoxins Market: Overall Company Footprint Analysis
3.4.1 Immunotoxins Market: Region Footprint
3.4.2 Immunotoxins Market: Company Product Type Footprint
3.4.3 Immunotoxins Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunotoxins Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunotoxins Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunotoxins Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunotoxins Consumption Value Comparison
4.2.1 United States VS China: Immunotoxins Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunotoxins Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunotoxins Companies and Market Share, 2021-2026
4.3.1 United States Based Immunotoxins Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunotoxins Revenue, (2021-2026)
4.4 China Based Companies Immunotoxins Revenue and Market Share, 2021-2026
4.4.1 China Based Immunotoxins Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunotoxins Revenue, (2021-2026)
4.5 Rest of World Based Immunotoxins Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunotoxins Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunotoxins Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunotoxins Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Anthrax Based Toxins
5.2.2 Diphtheria Toxin (DT) & DT Derivatives
5.2.3 Pseudomonas Exotoxin (PE) & PE Derivatives
5.2.4 Ribosome Inactivating Proteins Based Immunotoxins
5.2.5 Ribonucleases based Immunotoxins
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Immunotoxins Market Size by Type (2021-2026)
5.3.2 World Immunotoxins Market Size by Type (2027-2032)
5.3.3 World Immunotoxins Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MANUFACTURING METHOD
6.1 World Immunotoxins Market Size Overview by Manufacturing Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Manufacturing Method
6.2.1 Chemical Conjugation
6.2.2 Recombinant Fusion
6.2.3 Others
6.3 Market Segment by Manufacturing Method
6.3.1 World Immunotoxins Market Size by Manufacturing Method (2021-2026)
6.3.2 World Immunotoxins Market Size by Manufacturing Method (2027-2032)
6.3.3 World Immunotoxins Market Size Market Share by Manufacturing Method (2027-2032)
7 MARKET ANALYSIS BY TOXIN ORIGIN
7.1 World Immunotoxins Market Size Overview by Toxin Origin: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Toxin Origin
7.2.1 Bacterial-derived
7.2.2 Plant-derived
7.2.3 Synthetic-derived
7.2.4 Others
7.3 Market Segment by Toxin Origin
7.3.1 World Immunotoxins Market Size by Toxin Origin (2021-2026)
7.3.2 World Immunotoxins Market Size by Toxin Origin (2027-2032)
7.3.3 World Immunotoxins Market Size Market Share by Toxin Origin (2027-2032)
8 MARKET ANALYSIS BY MOLECULAR MODIFICATION
8.1 World Immunotoxins Market Size Overview by Molecular Modification: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Molecular Modification
8.2.1 PEGylated
8.2.2 Glycoengineered
8.2.3 Mutated Toxin
8.2.4 Others
8.3 Market Segment by Molecular Modification
8.3.1 World Immunotoxins Market Size by Molecular Modification (2021-2026)
8.3.2 World Immunotoxins Market Size by Molecular Modification (2027-2032)
8.3.3 World Immunotoxins Market Size Market Share by Molecular Modification (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Immunotoxins Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Solid Tumors
9.2.2 Leukemias
9.3 Market Segment by Application
9.3.1 World Immunotoxins Market Size by Application (2021-2026)
9.3.2 World Immunotoxins Market Size by Application (2027-2032)
9.3.3 World Immunotoxins Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Immunotoxins Product and Services
10.1.4 Roche Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Amgen
10.2.1 Amgen Details
10.2.2 Amgen Major Business
10.2.3 Amgen Immunotoxins Product and Services
10.2.4 Amgen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Amgen Recent Developments/Updates
10.2.6 Amgen Competitive Strengths & Weaknesses
10.3 Pfizer
10.3.1 Pfizer Details
10.3.2 Pfizer Major Business
10.3.3 Pfizer Immunotoxins Product and Services
10.3.4 Pfizer Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Pfizer Recent Developments/Updates
10.3.6 Pfizer Competitive Strengths & Weaknesses
10.4 Novartis
10.4.1 Novartis Details
10.4.2 Novartis Major Business
10.4.3 Novartis Immunotoxins Product and Services
10.4.4 Novartis Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Novartis Recent Developments/Updates
10.4.6 Novartis Competitive Strengths & Weaknesses
10.5 Bristol Myers Squibb
10.5.1 Bristol Myers Squibb Details
10.5.2 Bristol Myers Squibb Major Business
10.5.3 Bristol Myers Squibb Immunotoxins Product and Services
10.5.4 Bristol Myers Squibb Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Bristol Myers Squibb Recent Developments/Updates
10.5.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
10.6 AstraZeneca
10.6.1 AstraZeneca Details
10.6.2 AstraZeneca Major Business
10.6.3 AstraZeneca Immunotoxins Product and Services
10.6.4 AstraZeneca Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 AstraZeneca Recent Developments/Updates
10.6.6 AstraZeneca Competitive Strengths & Weaknesses
10.7 Sanofi
10.7.1 Sanofi Details
10.7.2 Sanofi Major Business
10.7.3 Sanofi Immunotoxins Product and Services
10.7.4 Sanofi Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Sanofi Recent Developments/Updates
10.7.6 Sanofi Competitive Strengths & Weaknesses
10.8 AbbVie
10.8.1 AbbVie Details
10.8.2 AbbVie Major Business
10.8.3 AbbVie Immunotoxins Product and Services
10.8.4 AbbVie Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 AbbVie Recent Developments/Updates
10.8.6 AbbVie Competitive Strengths & Weaknesses
10.9 Gilead Sciences
10.9.1 Gilead Sciences Details
10.9.2 Gilead Sciences Major Business
10.9.3 Gilead Sciences Immunotoxins Product and Services
10.9.4 Gilead Sciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Gilead Sciences Recent Developments/Updates
10.9.6 Gilead Sciences Competitive Strengths & Weaknesses
10.10 Regeneron Pharmaceuticals
10.10.1 Regeneron Pharmaceuticals Details
10.10.2 Regeneron Pharmaceuticals Major Business
10.10.3 Regeneron Pharmaceuticals Immunotoxins Product and Services
10.10.4 Regeneron Pharmaceuticals Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Regeneron Pharmaceuticals Recent Developments/Updates
10.10.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
10.11 Genentech
10.11.1 Genentech Details
10.11.2 Genentech Major Business
10.11.3 Genentech Immunotoxins Product and Services
10.11.4 Genentech Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Genentech Recent Developments/Updates
10.11.6 Genentech Competitive Strengths & Weaknesses
10.12 Genmab
10.12.1 Genmab Details
10.12.2 Genmab Major Business
10.12.3 Genmab Immunotoxins Product and Services
10.12.4 Genmab Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 Genmab Recent Developments/Updates
10.12.6 Genmab Competitive Strengths & Weaknesses
10.13 ImmunoGen
10.13.1 ImmunoGen Details
10.13.2 ImmunoGen Major Business
10.13.3 ImmunoGen Immunotoxins Product and Services
10.13.4 ImmunoGen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 ImmunoGen Recent Developments/Updates
10.13.6 ImmunoGen Competitive Strengths & Weaknesses
10.14 Seagen
10.14.1 Seagen Details
10.14.2 Seagen Major Business
10.14.3 Seagen Immunotoxins Product and Services
10.14.4 Seagen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Seagen Recent Developments/Updates
10.14.6 Seagen Competitive Strengths & Weaknesses
10.15 MacroGenics
10.15.1 MacroGenics Details
10.15.2 MacroGenics Major Business
10.15.3 MacroGenics Immunotoxins Product and Services
10.15.4 MacroGenics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 MacroGenics Recent Developments/Updates
10.15.6 MacroGenics Competitive Strengths & Weaknesses
10.16 Celldex Therapeutics
10.16.1 Celldex Therapeutics Details
10.16.2 Celldex Therapeutics Major Business
10.16.3 Celldex Therapeutics Immunotoxins Product and Services
10.16.4 Celldex Therapeutics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.16.5 Celldex Therapeutics Recent Developments/Updates
10.16.6 Celldex Therapeutics Competitive Strengths & Weaknesses
10.17 Ipsen
10.17.1 Ipsen Details
10.17.2 Ipsen Major Business
10.17.3 Ipsen Immunotoxins Product and Services
10.17.4 Ipsen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.17.5 Ipsen Recent Developments/Updates
10.17.6 Ipsen Competitive Strengths & Weaknesses
10.18 Takeda
10.18.1 Takeda Details
10.18.2 Takeda Major Business
10.18.3 Takeda Immunotoxins Product and Services
10.18.4 Takeda Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.18.5 Takeda Recent Developments/Updates
10.18.6 Takeda Competitive Strengths & Weaknesses
10.19 Eisai
10.19.1 Eisai Details
10.19.2 Eisai Major Business
10.19.3 Eisai Immunotoxins Product and Services
10.19.4 Eisai Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.19.5 Eisai Recent Developments/Updates
10.19.6 Eisai Competitive Strengths & Weaknesses
10.20 Chugai Pharmaceutical
10.20.1 Chugai Pharmaceutical Details
10.20.2 Chugai Pharmaceutical Major Business
10.20.3 Chugai Pharmaceutical Immunotoxins Product and Services
10.20.4 Chugai Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.20.5 Chugai Pharmaceutical Recent Developments/Updates
10.20.6 Chugai Pharmaceutical Competitive Strengths & Weaknesses
10.21 Samsung Biologics
10.21.1 Samsung Biologics Details
10.21.2 Samsung Biologics Major Business
10.21.3 Samsung Biologics Immunotoxins Product and Services
10.21.4 Samsung Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.21.5 Samsung Biologics Recent Developments/Updates
10.21.6 Samsung Biologics Competitive Strengths & Weaknesses
10.22 Lonza
10.22.1 Lonza Details
10.22.2 Lonza Major Business
10.22.3 Lonza Immunotoxins Product and Services
10.22.4 Lonza Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.22.5 Lonza Recent Developments/Updates
10.22.6 Lonza Competitive Strengths & Weaknesses
10.23 WuXi Biologics
10.23.1 WuXi Biologics Details
10.23.2 WuXi Biologics Major Business
10.23.3 WuXi Biologics Immunotoxins Product and Services
10.23.4 WuXi Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.23.5 WuXi Biologics Recent Developments/Updates
10.23.6 WuXi Biologics Competitive Strengths & Weaknesses
10.24 BeiGene
10.24.1 BeiGene Details
10.24.2 BeiGene Major Business
10.24.3 BeiGene Immunotoxins Product and Services
10.24.4 BeiGene Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.24.5 BeiGene Recent Developments/Updates
10.24.6 BeiGene Competitive Strengths & Weaknesses
10.25 Innovent Biologics
10.25.1 Innovent Biologics Details
10.25.2 Innovent Biologics Major Business
10.25.3 Innovent Biologics Immunotoxins Product and Services
10.25.4 Innovent Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.25.5 Innovent Biologics Recent Developments/Updates
10.25.6 Innovent Biologics Competitive Strengths & Weaknesses
10.26 Hengrui Medicine
10.26.1 Hengrui Medicine Details
10.26.2 Hengrui Medicine Major Business
10.26.3 Hengrui Medicine Immunotoxins Product and Services
10.26.4 Hengrui Medicine Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.26.5 Hengrui Medicine Recent Developments/Updates
10.26.6 Hengrui Medicine Competitive Strengths & Weaknesses
10.27 Fosun Pharma
10.27.1 Fosun Pharma Details
10.27.2 Fosun Pharma Major Business
10.27.3 Fosun Pharma Immunotoxins Product and Services
10.27.4 Fosun Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.27.5 Fosun Pharma Recent Developments/Updates
10.27.6 Fosun Pharma Competitive Strengths & Weaknesses
10.28 Junshi Biosciences
10.28.1 Junshi Biosciences Details
10.28.2 Junshi Biosciences Major Business
10.28.3 Junshi Biosciences Immunotoxins Product and Services
10.28.4 Junshi Biosciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.28.5 Junshi Biosciences Recent Developments/Updates
10.28.6 Junshi Biosciences Competitive Strengths & Weaknesses
10.29 CSPC Pharmaceutical
10.29.1 CSPC Pharmaceutical Details
10.29.2 CSPC Pharmaceutical Major Business
10.29.3 CSPC Pharmaceutical Immunotoxins Product and Services
10.29.4 CSPC Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.29.5 CSPC Pharmaceutical Recent Developments/Updates
10.29.6 CSPC Pharmaceutical Competitive Strengths & Weaknesses
10.30 Ascentage Pharma
10.30.1 Ascentage Pharma Details
10.30.2 Ascentage Pharma Major Business
10.30.3 Ascentage Pharma Immunotoxins Product and Services
10.30.4 Ascentage Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.30.5 Ascentage Pharma Recent Developments/Updates
10.30.6 Ascentage Pharma Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Immunotoxins Industry Chain
11.2 Immunotoxins Upstream Analysis
11.3 Immunotoxins Midstream Analysis
11.4 Immunotoxins Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Immunotoxins Introduction
1.2 World Immunotoxins Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunotoxins Total Market by Region (by Headquarter Location)
1.3.1 World Immunotoxins Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunotoxins Revenue (2021-2032)
1.3.3 China Based Company Immunotoxins Revenue (2021-2032)
1.3.4 Europe Based Company Immunotoxins Revenue (2021-2032)
1.3.5 Japan Based Company Immunotoxins Revenue (2021-2032)
1.3.6 South Korea Based Company Immunotoxins Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunotoxins Revenue (2021-2032)
1.3.8 India Based Company Immunotoxins Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunotoxins Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunotoxins Consumption Value (2021-2032)
2.2 World Immunotoxins Consumption Value by Region
2.2.1 World Immunotoxins Consumption Value by Region (2021-2026)
2.2.2 World Immunotoxins Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunotoxins Consumption Value (2021-2032)
2.4 China Immunotoxins Consumption Value (2021-2032)
2.5 Europe Immunotoxins Consumption Value (2021-2032)
2.6 Japan Immunotoxins Consumption Value (2021-2032)
2.7 South Korea Immunotoxins Consumption Value (2021-2032)
2.8 ASEAN Immunotoxins Consumption Value (2021-2032)
2.9 India Immunotoxins Consumption Value (2021-2032)
3 WORLD IMMUNOTOXINS COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunotoxins Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunotoxins Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunotoxins in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunotoxins in 2025
3.3 Immunotoxins Company Evaluation Quadrant
3.4 Immunotoxins Market: Overall Company Footprint Analysis
3.4.1 Immunotoxins Market: Region Footprint
3.4.2 Immunotoxins Market: Company Product Type Footprint
3.4.3 Immunotoxins Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunotoxins Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunotoxins Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunotoxins Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunotoxins Consumption Value Comparison
4.2.1 United States VS China: Immunotoxins Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunotoxins Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunotoxins Companies and Market Share, 2021-2026
4.3.1 United States Based Immunotoxins Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunotoxins Revenue, (2021-2026)
4.4 China Based Companies Immunotoxins Revenue and Market Share, 2021-2026
4.4.1 China Based Immunotoxins Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunotoxins Revenue, (2021-2026)
4.5 Rest of World Based Immunotoxins Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunotoxins Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunotoxins Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunotoxins Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Anthrax Based Toxins
5.2.2 Diphtheria Toxin (DT) & DT Derivatives
5.2.3 Pseudomonas Exotoxin (PE) & PE Derivatives
5.2.4 Ribosome Inactivating Proteins Based Immunotoxins
5.2.5 Ribonucleases based Immunotoxins
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Immunotoxins Market Size by Type (2021-2026)
5.3.2 World Immunotoxins Market Size by Type (2027-2032)
5.3.3 World Immunotoxins Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MANUFACTURING METHOD
6.1 World Immunotoxins Market Size Overview by Manufacturing Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Manufacturing Method
6.2.1 Chemical Conjugation
6.2.2 Recombinant Fusion
6.2.3 Others
6.3 Market Segment by Manufacturing Method
6.3.1 World Immunotoxins Market Size by Manufacturing Method (2021-2026)
6.3.2 World Immunotoxins Market Size by Manufacturing Method (2027-2032)
6.3.3 World Immunotoxins Market Size Market Share by Manufacturing Method (2027-2032)
7 MARKET ANALYSIS BY TOXIN ORIGIN
7.1 World Immunotoxins Market Size Overview by Toxin Origin: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Toxin Origin
7.2.1 Bacterial-derived
7.2.2 Plant-derived
7.2.3 Synthetic-derived
7.2.4 Others
7.3 Market Segment by Toxin Origin
7.3.1 World Immunotoxins Market Size by Toxin Origin (2021-2026)
7.3.2 World Immunotoxins Market Size by Toxin Origin (2027-2032)
7.3.3 World Immunotoxins Market Size Market Share by Toxin Origin (2027-2032)
8 MARKET ANALYSIS BY MOLECULAR MODIFICATION
8.1 World Immunotoxins Market Size Overview by Molecular Modification: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Molecular Modification
8.2.1 PEGylated
8.2.2 Glycoengineered
8.2.3 Mutated Toxin
8.2.4 Others
8.3 Market Segment by Molecular Modification
8.3.1 World Immunotoxins Market Size by Molecular Modification (2021-2026)
8.3.2 World Immunotoxins Market Size by Molecular Modification (2027-2032)
8.3.3 World Immunotoxins Market Size Market Share by Molecular Modification (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Immunotoxins Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Solid Tumors
9.2.2 Leukemias
9.3 Market Segment by Application
9.3.1 World Immunotoxins Market Size by Application (2021-2026)
9.3.2 World Immunotoxins Market Size by Application (2027-2032)
9.3.3 World Immunotoxins Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Immunotoxins Product and Services
10.1.4 Roche Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Amgen
10.2.1 Amgen Details
10.2.2 Amgen Major Business
10.2.3 Amgen Immunotoxins Product and Services
10.2.4 Amgen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Amgen Recent Developments/Updates
10.2.6 Amgen Competitive Strengths & Weaknesses
10.3 Pfizer
10.3.1 Pfizer Details
10.3.2 Pfizer Major Business
10.3.3 Pfizer Immunotoxins Product and Services
10.3.4 Pfizer Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Pfizer Recent Developments/Updates
10.3.6 Pfizer Competitive Strengths & Weaknesses
10.4 Novartis
10.4.1 Novartis Details
10.4.2 Novartis Major Business
10.4.3 Novartis Immunotoxins Product and Services
10.4.4 Novartis Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Novartis Recent Developments/Updates
10.4.6 Novartis Competitive Strengths & Weaknesses
10.5 Bristol Myers Squibb
10.5.1 Bristol Myers Squibb Details
10.5.2 Bristol Myers Squibb Major Business
10.5.3 Bristol Myers Squibb Immunotoxins Product and Services
10.5.4 Bristol Myers Squibb Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Bristol Myers Squibb Recent Developments/Updates
10.5.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
10.6 AstraZeneca
10.6.1 AstraZeneca Details
10.6.2 AstraZeneca Major Business
10.6.3 AstraZeneca Immunotoxins Product and Services
10.6.4 AstraZeneca Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 AstraZeneca Recent Developments/Updates
10.6.6 AstraZeneca Competitive Strengths & Weaknesses
10.7 Sanofi
10.7.1 Sanofi Details
10.7.2 Sanofi Major Business
10.7.3 Sanofi Immunotoxins Product and Services
10.7.4 Sanofi Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Sanofi Recent Developments/Updates
10.7.6 Sanofi Competitive Strengths & Weaknesses
10.8 AbbVie
10.8.1 AbbVie Details
10.8.2 AbbVie Major Business
10.8.3 AbbVie Immunotoxins Product and Services
10.8.4 AbbVie Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 AbbVie Recent Developments/Updates
10.8.6 AbbVie Competitive Strengths & Weaknesses
10.9 Gilead Sciences
10.9.1 Gilead Sciences Details
10.9.2 Gilead Sciences Major Business
10.9.3 Gilead Sciences Immunotoxins Product and Services
10.9.4 Gilead Sciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Gilead Sciences Recent Developments/Updates
10.9.6 Gilead Sciences Competitive Strengths & Weaknesses
10.10 Regeneron Pharmaceuticals
10.10.1 Regeneron Pharmaceuticals Details
10.10.2 Regeneron Pharmaceuticals Major Business
10.10.3 Regeneron Pharmaceuticals Immunotoxins Product and Services
10.10.4 Regeneron Pharmaceuticals Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Regeneron Pharmaceuticals Recent Developments/Updates
10.10.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
10.11 Genentech
10.11.1 Genentech Details
10.11.2 Genentech Major Business
10.11.3 Genentech Immunotoxins Product and Services
10.11.4 Genentech Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Genentech Recent Developments/Updates
10.11.6 Genentech Competitive Strengths & Weaknesses
10.12 Genmab
10.12.1 Genmab Details
10.12.2 Genmab Major Business
10.12.3 Genmab Immunotoxins Product and Services
10.12.4 Genmab Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 Genmab Recent Developments/Updates
10.12.6 Genmab Competitive Strengths & Weaknesses
10.13 ImmunoGen
10.13.1 ImmunoGen Details
10.13.2 ImmunoGen Major Business
10.13.3 ImmunoGen Immunotoxins Product and Services
10.13.4 ImmunoGen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 ImmunoGen Recent Developments/Updates
10.13.6 ImmunoGen Competitive Strengths & Weaknesses
10.14 Seagen
10.14.1 Seagen Details
10.14.2 Seagen Major Business
10.14.3 Seagen Immunotoxins Product and Services
10.14.4 Seagen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Seagen Recent Developments/Updates
10.14.6 Seagen Competitive Strengths & Weaknesses
10.15 MacroGenics
10.15.1 MacroGenics Details
10.15.2 MacroGenics Major Business
10.15.3 MacroGenics Immunotoxins Product and Services
10.15.4 MacroGenics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 MacroGenics Recent Developments/Updates
10.15.6 MacroGenics Competitive Strengths & Weaknesses
10.16 Celldex Therapeutics
10.16.1 Celldex Therapeutics Details
10.16.2 Celldex Therapeutics Major Business
10.16.3 Celldex Therapeutics Immunotoxins Product and Services
10.16.4 Celldex Therapeutics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.16.5 Celldex Therapeutics Recent Developments/Updates
10.16.6 Celldex Therapeutics Competitive Strengths & Weaknesses
10.17 Ipsen
10.17.1 Ipsen Details
10.17.2 Ipsen Major Business
10.17.3 Ipsen Immunotoxins Product and Services
10.17.4 Ipsen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.17.5 Ipsen Recent Developments/Updates
10.17.6 Ipsen Competitive Strengths & Weaknesses
10.18 Takeda
10.18.1 Takeda Details
10.18.2 Takeda Major Business
10.18.3 Takeda Immunotoxins Product and Services
10.18.4 Takeda Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.18.5 Takeda Recent Developments/Updates
10.18.6 Takeda Competitive Strengths & Weaknesses
10.19 Eisai
10.19.1 Eisai Details
10.19.2 Eisai Major Business
10.19.3 Eisai Immunotoxins Product and Services
10.19.4 Eisai Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.19.5 Eisai Recent Developments/Updates
10.19.6 Eisai Competitive Strengths & Weaknesses
10.20 Chugai Pharmaceutical
10.20.1 Chugai Pharmaceutical Details
10.20.2 Chugai Pharmaceutical Major Business
10.20.3 Chugai Pharmaceutical Immunotoxins Product and Services
10.20.4 Chugai Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.20.5 Chugai Pharmaceutical Recent Developments/Updates
10.20.6 Chugai Pharmaceutical Competitive Strengths & Weaknesses
10.21 Samsung Biologics
10.21.1 Samsung Biologics Details
10.21.2 Samsung Biologics Major Business
10.21.3 Samsung Biologics Immunotoxins Product and Services
10.21.4 Samsung Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.21.5 Samsung Biologics Recent Developments/Updates
10.21.6 Samsung Biologics Competitive Strengths & Weaknesses
10.22 Lonza
10.22.1 Lonza Details
10.22.2 Lonza Major Business
10.22.3 Lonza Immunotoxins Product and Services
10.22.4 Lonza Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.22.5 Lonza Recent Developments/Updates
10.22.6 Lonza Competitive Strengths & Weaknesses
10.23 WuXi Biologics
10.23.1 WuXi Biologics Details
10.23.2 WuXi Biologics Major Business
10.23.3 WuXi Biologics Immunotoxins Product and Services
10.23.4 WuXi Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.23.5 WuXi Biologics Recent Developments/Updates
10.23.6 WuXi Biologics Competitive Strengths & Weaknesses
10.24 BeiGene
10.24.1 BeiGene Details
10.24.2 BeiGene Major Business
10.24.3 BeiGene Immunotoxins Product and Services
10.24.4 BeiGene Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.24.5 BeiGene Recent Developments/Updates
10.24.6 BeiGene Competitive Strengths & Weaknesses
10.25 Innovent Biologics
10.25.1 Innovent Biologics Details
10.25.2 Innovent Biologics Major Business
10.25.3 Innovent Biologics Immunotoxins Product and Services
10.25.4 Innovent Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.25.5 Innovent Biologics Recent Developments/Updates
10.25.6 Innovent Biologics Competitive Strengths & Weaknesses
10.26 Hengrui Medicine
10.26.1 Hengrui Medicine Details
10.26.2 Hengrui Medicine Major Business
10.26.3 Hengrui Medicine Immunotoxins Product and Services
10.26.4 Hengrui Medicine Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.26.5 Hengrui Medicine Recent Developments/Updates
10.26.6 Hengrui Medicine Competitive Strengths & Weaknesses
10.27 Fosun Pharma
10.27.1 Fosun Pharma Details
10.27.2 Fosun Pharma Major Business
10.27.3 Fosun Pharma Immunotoxins Product and Services
10.27.4 Fosun Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.27.5 Fosun Pharma Recent Developments/Updates
10.27.6 Fosun Pharma Competitive Strengths & Weaknesses
10.28 Junshi Biosciences
10.28.1 Junshi Biosciences Details
10.28.2 Junshi Biosciences Major Business
10.28.3 Junshi Biosciences Immunotoxins Product and Services
10.28.4 Junshi Biosciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.28.5 Junshi Biosciences Recent Developments/Updates
10.28.6 Junshi Biosciences Competitive Strengths & Weaknesses
10.29 CSPC Pharmaceutical
10.29.1 CSPC Pharmaceutical Details
10.29.2 CSPC Pharmaceutical Major Business
10.29.3 CSPC Pharmaceutical Immunotoxins Product and Services
10.29.4 CSPC Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.29.5 CSPC Pharmaceutical Recent Developments/Updates
10.29.6 CSPC Pharmaceutical Competitive Strengths & Weaknesses
10.30 Ascentage Pharma
10.30.1 Ascentage Pharma Details
10.30.2 Ascentage Pharma Major Business
10.30.3 Ascentage Pharma Immunotoxins Product and Services
10.30.4 Ascentage Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026)
10.30.5 Ascentage Pharma Recent Developments/Updates
10.30.6 Ascentage Pharma Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Immunotoxins Industry Chain
11.2 Immunotoxins Upstream Analysis
11.3 Immunotoxins Midstream Analysis
11.4 Immunotoxins Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Immunotoxins Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunotoxins Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunotoxins Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunotoxins Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunotoxins Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunotoxins Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunotoxins Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunotoxins Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunotoxins Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunotoxins Players in 2025
Table 12. World Immunotoxins Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunotoxins Company Evaluation Quadrant
Table 14. Head Office of Key Immunotoxins Players
Table 15. Immunotoxins Market: Company Product Type Footprint
Table 16. Immunotoxins Market: Company Product Application Footprint
Table 17. Immunotoxins Mergers & Acquisitions Activity
Table 18. United States VS China Immunotoxins Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunotoxins Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunotoxins Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunotoxins Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunotoxins Revenue Market Share (2021-2026)
Table 23. China Based Immunotoxins Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunotoxins Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunotoxins Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunotoxins Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunotoxins Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunotoxins Revenue Market Share (2021-2026)
Table 29. World Immunotoxins Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunotoxins Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunotoxins Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunotoxins Market Size by Manufacturing Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunotoxins Market Size Value by Manufacturing Method (2021-2026) & (USD Million)
Table 34. World Immunotoxins Market Size by Manufacturing Method (2027-2032) & (USD Million)
Table 35. World Immunotoxins Market Size by Toxin Origin, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunotoxins Market Size Value by Toxin Origin (2021-2026) & (USD Million)
Table 37. World Immunotoxins Market Size by Toxin Origin (2027-2032) & (USD Million)
Table 38. World Immunotoxins Market Size by Molecular Modification, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunotoxins Market Size Value by Molecular Modification (2021-2026) & (USD Million)
Table 40. World Immunotoxins Market Size by Molecular Modification (2027-2032) & (USD Million)
Table 41. World Immunotoxins Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Immunotoxins Market Size by Application (2021-2026) & (USD Million)
Table 43. World Immunotoxins Market Size by Application (2027-2032) & (USD Million)
Table 44. Roche Basic Information, Manufacturing Base and Competitors
Table 45. Roche Major Business
Table 46. Roche Immunotoxins Product and Services
Table 47. Roche Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Roche Recent Developments/Updates
Table 49. Roche Competitive Strengths & Weaknesses
Table 50. Amgen Basic Information, Manufacturing Base and Competitors
Table 51. Amgen Major Business
Table 52. Amgen Immunotoxins Product and Services
Table 53. Amgen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Amgen Recent Developments/Updates
Table 55. Amgen Competitive Strengths & Weaknesses
Table 56. Pfizer Basic Information, Manufacturing Base and Competitors
Table 57. Pfizer Major Business
Table 58. Pfizer Immunotoxins Product and Services
Table 59. Pfizer Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Pfizer Recent Developments/Updates
Table 61. Pfizer Competitive Strengths & Weaknesses
Table 62. Novartis Basic Information, Manufacturing Base and Competitors
Table 63. Novartis Major Business
Table 64. Novartis Immunotoxins Product and Services
Table 65. Novartis Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Novartis Recent Developments/Updates
Table 67. Novartis Competitive Strengths & Weaknesses
Table 68. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 69. Bristol Myers Squibb Major Business
Table 70. Bristol Myers Squibb Immunotoxins Product and Services
Table 71. Bristol Myers Squibb Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Bristol Myers Squibb Recent Developments/Updates
Table 73. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 74. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 75. AstraZeneca Major Business
Table 76. AstraZeneca Immunotoxins Product and Services
Table 77. AstraZeneca Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. AstraZeneca Recent Developments/Updates
Table 79. AstraZeneca Competitive Strengths & Weaknesses
Table 80. Sanofi Basic Information, Manufacturing Base and Competitors
Table 81. Sanofi Major Business
Table 82. Sanofi Immunotoxins Product and Services
Table 83. Sanofi Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Sanofi Recent Developments/Updates
Table 85. Sanofi Competitive Strengths & Weaknesses
Table 86. AbbVie Basic Information, Manufacturing Base and Competitors
Table 87. AbbVie Major Business
Table 88. AbbVie Immunotoxins Product and Services
Table 89. AbbVie Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. AbbVie Recent Developments/Updates
Table 91. AbbVie Competitive Strengths & Weaknesses
Table 92. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 93. Gilead Sciences Major Business
Table 94. Gilead Sciences Immunotoxins Product and Services
Table 95. Gilead Sciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Gilead Sciences Recent Developments/Updates
Table 97. Gilead Sciences Competitive Strengths & Weaknesses
Table 98. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Regeneron Pharmaceuticals Major Business
Table 100. Regeneron Pharmaceuticals Immunotoxins Product and Services
Table 101. Regeneron Pharmaceuticals Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Regeneron Pharmaceuticals Recent Developments/Updates
Table 103. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 104. Genentech Basic Information, Manufacturing Base and Competitors
Table 105. Genentech Major Business
Table 106. Genentech Immunotoxins Product and Services
Table 107. Genentech Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Genentech Recent Developments/Updates
Table 109. Genentech Competitive Strengths & Weaknesses
Table 110. Genmab Basic Information, Manufacturing Base and Competitors
Table 111. Genmab Major Business
Table 112. Genmab Immunotoxins Product and Services
Table 113. Genmab Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Genmab Recent Developments/Updates
Table 115. Genmab Competitive Strengths & Weaknesses
Table 116. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 117. ImmunoGen Major Business
Table 118. ImmunoGen Immunotoxins Product and Services
Table 119. ImmunoGen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. ImmunoGen Recent Developments/Updates
Table 121. ImmunoGen Competitive Strengths & Weaknesses
Table 122. Seagen Basic Information, Manufacturing Base and Competitors
Table 123. Seagen Major Business
Table 124. Seagen Immunotoxins Product and Services
Table 125. Seagen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Seagen Recent Developments/Updates
Table 127. Seagen Competitive Strengths & Weaknesses
Table 128. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 129. MacroGenics Major Business
Table 130. MacroGenics Immunotoxins Product and Services
Table 131. MacroGenics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. MacroGenics Recent Developments/Updates
Table 133. MacroGenics Competitive Strengths & Weaknesses
Table 134. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 135. Celldex Therapeutics Major Business
Table 136. Celldex Therapeutics Immunotoxins Product and Services
Table 137. Celldex Therapeutics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Celldex Therapeutics Recent Developments/Updates
Table 139. Celldex Therapeutics Competitive Strengths & Weaknesses
Table 140. Ipsen Basic Information, Manufacturing Base and Competitors
Table 141. Ipsen Major Business
Table 142. Ipsen Immunotoxins Product and Services
Table 143. Ipsen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Ipsen Recent Developments/Updates
Table 145. Ipsen Competitive Strengths & Weaknesses
Table 146. Takeda Basic Information, Manufacturing Base and Competitors
Table 147. Takeda Major Business
Table 148. Takeda Immunotoxins Product and Services
Table 149. Takeda Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Takeda Recent Developments/Updates
Table 151. Takeda Competitive Strengths & Weaknesses
Table 152. Eisai Basic Information, Manufacturing Base and Competitors
Table 153. Eisai Major Business
Table 154. Eisai Immunotoxins Product and Services
Table 155. Eisai Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Eisai Recent Developments/Updates
Table 157. Eisai Competitive Strengths & Weaknesses
Table 158. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 159. Chugai Pharmaceutical Major Business
Table 160. Chugai Pharmaceutical Immunotoxins Product and Services
Table 161. Chugai Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Chugai Pharmaceutical Recent Developments/Updates
Table 163. Chugai Pharmaceutical Competitive Strengths & Weaknesses
Table 164. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 165. Samsung Biologics Major Business
Table 166. Samsung Biologics Immunotoxins Product and Services
Table 167. Samsung Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Samsung Biologics Recent Developments/Updates
Table 169. Samsung Biologics Competitive Strengths & Weaknesses
Table 170. Lonza Basic Information, Manufacturing Base and Competitors
Table 171. Lonza Major Business
Table 172. Lonza Immunotoxins Product and Services
Table 173. Lonza Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 174. Lonza Recent Developments/Updates
Table 175. Lonza Competitive Strengths & Weaknesses
Table 176. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 177. WuXi Biologics Major Business
Table 178. WuXi Biologics Immunotoxins Product and Services
Table 179. WuXi Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 180. WuXi Biologics Recent Developments/Updates
Table 181. WuXi Biologics Competitive Strengths & Weaknesses
Table 182. BeiGene Basic Information, Manufacturing Base and Competitors
Table 183. BeiGene Major Business
Table 184. BeiGene Immunotoxins Product and Services
Table 185. BeiGene Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 186. BeiGene Recent Developments/Updates
Table 187. BeiGene Competitive Strengths & Weaknesses
Table 188. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 189. Innovent Biologics Major Business
Table 190. Innovent Biologics Immunotoxins Product and Services
Table 191. Innovent Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 192. Innovent Biologics Recent Developments/Updates
Table 193. Innovent Biologics Competitive Strengths & Weaknesses
Table 194. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 195. Hengrui Medicine Major Business
Table 196. Hengrui Medicine Immunotoxins Product and Services
Table 197. Hengrui Medicine Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 198. Hengrui Medicine Recent Developments/Updates
Table 199. Hengrui Medicine Competitive Strengths & Weaknesses
Table 200. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 201. Fosun Pharma Major Business
Table 202. Fosun Pharma Immunotoxins Product and Services
Table 203. Fosun Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 204. Fosun Pharma Recent Developments/Updates
Table 205. Fosun Pharma Competitive Strengths & Weaknesses
Table 206. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 207. Junshi Biosciences Major Business
Table 208. Junshi Biosciences Immunotoxins Product and Services
Table 209. Junshi Biosciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 210. Junshi Biosciences Recent Developments/Updates
Table 211. Junshi Biosciences Competitive Strengths & Weaknesses
Table 212. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 213. CSPC Pharmaceutical Major Business
Table 214. CSPC Pharmaceutical Immunotoxins Product and Services
Table 215. CSPC Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 216. CSPC Pharmaceutical Recent Developments/Updates
Table 217. CSPC Pharmaceutical Competitive Strengths & Weaknesses
Table 218. Ascentage Pharma Basic Information, Manufacturing Base and Competitors
Table 219. Ascentage Pharma Major Business
Table 220. Ascentage Pharma Immunotoxins Product and Services
Table 221. Ascentage Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 222. Ascentage Pharma Recent Developments/Updates
Table 223. Ascentage Pharma Competitive Strengths & Weaknesses
Table 224. Global Key Players of Immunotoxins Upstream (Raw Materials)
Table 225. Global Immunotoxins Typical Customers
Table 1. World Immunotoxins Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunotoxins Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunotoxins Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunotoxins Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunotoxins Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunotoxins Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunotoxins Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunotoxins Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunotoxins Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunotoxins Players in 2025
Table 12. World Immunotoxins Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunotoxins Company Evaluation Quadrant
Table 14. Head Office of Key Immunotoxins Players
Table 15. Immunotoxins Market: Company Product Type Footprint
Table 16. Immunotoxins Market: Company Product Application Footprint
Table 17. Immunotoxins Mergers & Acquisitions Activity
Table 18. United States VS China Immunotoxins Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunotoxins Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunotoxins Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunotoxins Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunotoxins Revenue Market Share (2021-2026)
Table 23. China Based Immunotoxins Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunotoxins Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunotoxins Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunotoxins Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunotoxins Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunotoxins Revenue Market Share (2021-2026)
Table 29. World Immunotoxins Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunotoxins Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunotoxins Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunotoxins Market Size by Manufacturing Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunotoxins Market Size Value by Manufacturing Method (2021-2026) & (USD Million)
Table 34. World Immunotoxins Market Size by Manufacturing Method (2027-2032) & (USD Million)
Table 35. World Immunotoxins Market Size by Toxin Origin, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunotoxins Market Size Value by Toxin Origin (2021-2026) & (USD Million)
Table 37. World Immunotoxins Market Size by Toxin Origin (2027-2032) & (USD Million)
Table 38. World Immunotoxins Market Size by Molecular Modification, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunotoxins Market Size Value by Molecular Modification (2021-2026) & (USD Million)
Table 40. World Immunotoxins Market Size by Molecular Modification (2027-2032) & (USD Million)
Table 41. World Immunotoxins Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Immunotoxins Market Size by Application (2021-2026) & (USD Million)
Table 43. World Immunotoxins Market Size by Application (2027-2032) & (USD Million)
Table 44. Roche Basic Information, Manufacturing Base and Competitors
Table 45. Roche Major Business
Table 46. Roche Immunotoxins Product and Services
Table 47. Roche Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Roche Recent Developments/Updates
Table 49. Roche Competitive Strengths & Weaknesses
Table 50. Amgen Basic Information, Manufacturing Base and Competitors
Table 51. Amgen Major Business
Table 52. Amgen Immunotoxins Product and Services
Table 53. Amgen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Amgen Recent Developments/Updates
Table 55. Amgen Competitive Strengths & Weaknesses
Table 56. Pfizer Basic Information, Manufacturing Base and Competitors
Table 57. Pfizer Major Business
Table 58. Pfizer Immunotoxins Product and Services
Table 59. Pfizer Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Pfizer Recent Developments/Updates
Table 61. Pfizer Competitive Strengths & Weaknesses
Table 62. Novartis Basic Information, Manufacturing Base and Competitors
Table 63. Novartis Major Business
Table 64. Novartis Immunotoxins Product and Services
Table 65. Novartis Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Novartis Recent Developments/Updates
Table 67. Novartis Competitive Strengths & Weaknesses
Table 68. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 69. Bristol Myers Squibb Major Business
Table 70. Bristol Myers Squibb Immunotoxins Product and Services
Table 71. Bristol Myers Squibb Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Bristol Myers Squibb Recent Developments/Updates
Table 73. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 74. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 75. AstraZeneca Major Business
Table 76. AstraZeneca Immunotoxins Product and Services
Table 77. AstraZeneca Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. AstraZeneca Recent Developments/Updates
Table 79. AstraZeneca Competitive Strengths & Weaknesses
Table 80. Sanofi Basic Information, Manufacturing Base and Competitors
Table 81. Sanofi Major Business
Table 82. Sanofi Immunotoxins Product and Services
Table 83. Sanofi Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Sanofi Recent Developments/Updates
Table 85. Sanofi Competitive Strengths & Weaknesses
Table 86. AbbVie Basic Information, Manufacturing Base and Competitors
Table 87. AbbVie Major Business
Table 88. AbbVie Immunotoxins Product and Services
Table 89. AbbVie Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. AbbVie Recent Developments/Updates
Table 91. AbbVie Competitive Strengths & Weaknesses
Table 92. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 93. Gilead Sciences Major Business
Table 94. Gilead Sciences Immunotoxins Product and Services
Table 95. Gilead Sciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Gilead Sciences Recent Developments/Updates
Table 97. Gilead Sciences Competitive Strengths & Weaknesses
Table 98. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Regeneron Pharmaceuticals Major Business
Table 100. Regeneron Pharmaceuticals Immunotoxins Product and Services
Table 101. Regeneron Pharmaceuticals Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Regeneron Pharmaceuticals Recent Developments/Updates
Table 103. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 104. Genentech Basic Information, Manufacturing Base and Competitors
Table 105. Genentech Major Business
Table 106. Genentech Immunotoxins Product and Services
Table 107. Genentech Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Genentech Recent Developments/Updates
Table 109. Genentech Competitive Strengths & Weaknesses
Table 110. Genmab Basic Information, Manufacturing Base and Competitors
Table 111. Genmab Major Business
Table 112. Genmab Immunotoxins Product and Services
Table 113. Genmab Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Genmab Recent Developments/Updates
Table 115. Genmab Competitive Strengths & Weaknesses
Table 116. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 117. ImmunoGen Major Business
Table 118. ImmunoGen Immunotoxins Product and Services
Table 119. ImmunoGen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. ImmunoGen Recent Developments/Updates
Table 121. ImmunoGen Competitive Strengths & Weaknesses
Table 122. Seagen Basic Information, Manufacturing Base and Competitors
Table 123. Seagen Major Business
Table 124. Seagen Immunotoxins Product and Services
Table 125. Seagen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Seagen Recent Developments/Updates
Table 127. Seagen Competitive Strengths & Weaknesses
Table 128. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 129. MacroGenics Major Business
Table 130. MacroGenics Immunotoxins Product and Services
Table 131. MacroGenics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. MacroGenics Recent Developments/Updates
Table 133. MacroGenics Competitive Strengths & Weaknesses
Table 134. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 135. Celldex Therapeutics Major Business
Table 136. Celldex Therapeutics Immunotoxins Product and Services
Table 137. Celldex Therapeutics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Celldex Therapeutics Recent Developments/Updates
Table 139. Celldex Therapeutics Competitive Strengths & Weaknesses
Table 140. Ipsen Basic Information, Manufacturing Base and Competitors
Table 141. Ipsen Major Business
Table 142. Ipsen Immunotoxins Product and Services
Table 143. Ipsen Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Ipsen Recent Developments/Updates
Table 145. Ipsen Competitive Strengths & Weaknesses
Table 146. Takeda Basic Information, Manufacturing Base and Competitors
Table 147. Takeda Major Business
Table 148. Takeda Immunotoxins Product and Services
Table 149. Takeda Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Takeda Recent Developments/Updates
Table 151. Takeda Competitive Strengths & Weaknesses
Table 152. Eisai Basic Information, Manufacturing Base and Competitors
Table 153. Eisai Major Business
Table 154. Eisai Immunotoxins Product and Services
Table 155. Eisai Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Eisai Recent Developments/Updates
Table 157. Eisai Competitive Strengths & Weaknesses
Table 158. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 159. Chugai Pharmaceutical Major Business
Table 160. Chugai Pharmaceutical Immunotoxins Product and Services
Table 161. Chugai Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Chugai Pharmaceutical Recent Developments/Updates
Table 163. Chugai Pharmaceutical Competitive Strengths & Weaknesses
Table 164. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 165. Samsung Biologics Major Business
Table 166. Samsung Biologics Immunotoxins Product and Services
Table 167. Samsung Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Samsung Biologics Recent Developments/Updates
Table 169. Samsung Biologics Competitive Strengths & Weaknesses
Table 170. Lonza Basic Information, Manufacturing Base and Competitors
Table 171. Lonza Major Business
Table 172. Lonza Immunotoxins Product and Services
Table 173. Lonza Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 174. Lonza Recent Developments/Updates
Table 175. Lonza Competitive Strengths & Weaknesses
Table 176. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 177. WuXi Biologics Major Business
Table 178. WuXi Biologics Immunotoxins Product and Services
Table 179. WuXi Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 180. WuXi Biologics Recent Developments/Updates
Table 181. WuXi Biologics Competitive Strengths & Weaknesses
Table 182. BeiGene Basic Information, Manufacturing Base and Competitors
Table 183. BeiGene Major Business
Table 184. BeiGene Immunotoxins Product and Services
Table 185. BeiGene Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 186. BeiGene Recent Developments/Updates
Table 187. BeiGene Competitive Strengths & Weaknesses
Table 188. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 189. Innovent Biologics Major Business
Table 190. Innovent Biologics Immunotoxins Product and Services
Table 191. Innovent Biologics Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 192. Innovent Biologics Recent Developments/Updates
Table 193. Innovent Biologics Competitive Strengths & Weaknesses
Table 194. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 195. Hengrui Medicine Major Business
Table 196. Hengrui Medicine Immunotoxins Product and Services
Table 197. Hengrui Medicine Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 198. Hengrui Medicine Recent Developments/Updates
Table 199. Hengrui Medicine Competitive Strengths & Weaknesses
Table 200. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 201. Fosun Pharma Major Business
Table 202. Fosun Pharma Immunotoxins Product and Services
Table 203. Fosun Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 204. Fosun Pharma Recent Developments/Updates
Table 205. Fosun Pharma Competitive Strengths & Weaknesses
Table 206. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 207. Junshi Biosciences Major Business
Table 208. Junshi Biosciences Immunotoxins Product and Services
Table 209. Junshi Biosciences Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 210. Junshi Biosciences Recent Developments/Updates
Table 211. Junshi Biosciences Competitive Strengths & Weaknesses
Table 212. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 213. CSPC Pharmaceutical Major Business
Table 214. CSPC Pharmaceutical Immunotoxins Product and Services
Table 215. CSPC Pharmaceutical Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 216. CSPC Pharmaceutical Recent Developments/Updates
Table 217. CSPC Pharmaceutical Competitive Strengths & Weaknesses
Table 218. Ascentage Pharma Basic Information, Manufacturing Base and Competitors
Table 219. Ascentage Pharma Major Business
Table 220. Ascentage Pharma Immunotoxins Product and Services
Table 221. Ascentage Pharma Immunotoxins Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 222. Ascentage Pharma Recent Developments/Updates
Table 223. Ascentage Pharma Competitive Strengths & Weaknesses
Table 224. Global Key Players of Immunotoxins Upstream (Raw Materials)
Table 225. Global Immunotoxins Typical Customers
LIST OF FIGURES
Figure 1. Immunotoxins Picture
Figure 2. World Immunotoxins Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunotoxins Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunotoxins Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunotoxins Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 13. Immunotoxins Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunotoxins Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunotoxins by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunotoxins Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunotoxins Markets in 2025
Figure 27. United States VS China: Immunotoxins Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunotoxins Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunotoxins Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunotoxins Market Size Market Share by Type in 2025
Figure 31. Anthrax Based Toxins
Figure 32. Diphtheria Toxin (DT) & DT Derivatives
Figure 33. Pseudomonas Exotoxin (PE) & PE Derivatives
Figure 34. Ribosome Inactivating Proteins Based Immunotoxins
Figure 35. Ribonucleases based Immunotoxins
Figure 36. Others
Figure 37. World Immunotoxins Market Size Market Share by Type (2021-2032)
Figure 38. World Immunotoxins Market Size by Manufacturing Method, (USD Million), 2021 & 2025 & 2032
Figure 39. World Immunotoxins Market Size Market Share by Manufacturing Method in 2025
Figure 40. Chemical Conjugation
Figure 41. Recombinant Fusion
Figure 42. Others
Figure 43. World Immunotoxins Market Size Market Share by Manufacturing Method (2021-2032)
Figure 44. World Immunotoxins Market Size by Toxin Origin, (USD Million), 2021 & 2025 & 2032
Figure 45. World Immunotoxins Market Size Market Share by Toxin Origin in 2025
Figure 46. Bacterial-derived
Figure 47. Plant-derived
Figure 48. Synthetic-derived
Figure 49. Others
Figure 50. World Immunotoxins Market Size Market Share by Toxin Origin (2021-2032)
Figure 51. World Immunotoxins Market Size by Molecular Modification, (USD Million), 2021 & 2025 & 2032
Figure 52. World Immunotoxins Market Size Market Share by Molecular Modification in 2025
Figure 53. PEGylated
Figure 54. Glycoengineered
Figure 55. Mutated Toxin
Figure 56. Others
Figure 57. World Immunotoxins Market Size Market Share by Molecular Modification (2021-2032)
Figure 58. World Immunotoxins Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Immunotoxins Market Size Market Share by Application in 2025
Figure 60. Solid Tumors
Figure 61. Leukemias
Figure 62. World Immunotoxins Market Size Market Share by Application (2021-2032)
Figure 63. Immunotoxins Industrial Chain
Figure 64. Methodology
Figure 65. Research Process and Data Source
Figure 1. Immunotoxins Picture
Figure 2. World Immunotoxins Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunotoxins Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunotoxins Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunotoxins Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunotoxins Revenue (2021-2032) & (USD Million)
Figure 13. Immunotoxins Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunotoxins Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunotoxins Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunotoxins by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunotoxins Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunotoxins Markets in 2025
Figure 27. United States VS China: Immunotoxins Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunotoxins Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunotoxins Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunotoxins Market Size Market Share by Type in 2025
Figure 31. Anthrax Based Toxins
Figure 32. Diphtheria Toxin (DT) & DT Derivatives
Figure 33. Pseudomonas Exotoxin (PE) & PE Derivatives
Figure 34. Ribosome Inactivating Proteins Based Immunotoxins
Figure 35. Ribonucleases based Immunotoxins
Figure 36. Others
Figure 37. World Immunotoxins Market Size Market Share by Type (2021-2032)
Figure 38. World Immunotoxins Market Size by Manufacturing Method, (USD Million), 2021 & 2025 & 2032
Figure 39. World Immunotoxins Market Size Market Share by Manufacturing Method in 2025
Figure 40. Chemical Conjugation
Figure 41. Recombinant Fusion
Figure 42. Others
Figure 43. World Immunotoxins Market Size Market Share by Manufacturing Method (2021-2032)
Figure 44. World Immunotoxins Market Size by Toxin Origin, (USD Million), 2021 & 2025 & 2032
Figure 45. World Immunotoxins Market Size Market Share by Toxin Origin in 2025
Figure 46. Bacterial-derived
Figure 47. Plant-derived
Figure 48. Synthetic-derived
Figure 49. Others
Figure 50. World Immunotoxins Market Size Market Share by Toxin Origin (2021-2032)
Figure 51. World Immunotoxins Market Size by Molecular Modification, (USD Million), 2021 & 2025 & 2032
Figure 52. World Immunotoxins Market Size Market Share by Molecular Modification in 2025
Figure 53. PEGylated
Figure 54. Glycoengineered
Figure 55. Mutated Toxin
Figure 56. Others
Figure 57. World Immunotoxins Market Size Market Share by Molecular Modification (2021-2032)
Figure 58. World Immunotoxins Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Immunotoxins Market Size Market Share by Application in 2025
Figure 60. Solid Tumors
Figure 61. Leukemias
Figure 62. World Immunotoxins Market Size Market Share by Application (2021-2032)
Figure 63. Immunotoxins Industrial Chain
Figure 64. Methodology
Figure 65. Research Process and Data Source
